Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$43.44
-0.23%
Mkt Cap $2.64B
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (10 analysts)
$60.00
Range $55.00 – $65.00
Implied Upside
+38.1%
Consensus $60.00 vs current $43.44